维生素D缺乏防治-美国内分泌协会-20112010131851.DOC

维生素D缺乏评估、防治指南-美国内分泌协会-2011 2011-06-13 18:51:27 作者：zhinanwang 浏览次数：91 评论 0 条 指南全称： 维生素D缺乏评估、防治指南-美国内分泌协会-2011 英文全称： Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline 开发组织 ： Endocrine Society (内分泌协会) 开发年代 ： 2011 下载次数 ： 70 次  指南简介： Objective: The objective was to provide guidelines to clinicians for the evaluation, treatment, and prevention of vitamin D deficiency with an emphasis on the care of patients who are at risk for deficiency. Participants: The Task Force was composed of a Chair, six additional experts, and a methodologist. The Task Force received no corporate funding or remuneration. Consensus Process: Consensus was guided by systematic reviews of evidence and discussions during several conference calls and e-mail communications. The draft prepared by the Task Force was reviewed successively by The Endocrine Societys Clinical Guidelines Subcommittee, Clinical Affairs Core Committee, and cosponsoring associations, and it was posted on The Endocrine Society web site for member review. At each stage of review, the Task Force received written comments and incorporated needed changes. Conclusions: Considering that vitamin D deficiency is very common in all age groups and that few foods contain vitamin D, the Task Force recommended supplementation at suggested daily intake and tolerable upper limit levels, depending on age and clinical circumstances. The Task Force also suggested the measurement of serum 25-hydroxyvitamin D level by a reliable assay as the initial diagnostic test in patients at risk for deficiency. Treatment with either vitamin D(2) or vitamin D(3) was recommended for deficient patients. At the present time, there is not sufficient evidence to recommend screening individuals who are not at risk for deficiency or to prescribe vitamin D to attain the noncalcemic benefit for cardiovascular protection. 关键字： 维生素缺乏评估 2型糖尿病患者高血糖的治疗开始及调整方案的共识(英文) 2008 2011-05-29